Connect with us

Business

Morison commences local production of three high-in-demand medicines

Published

on

Morison Ltd., a pioneer in pharmaceutical manufacturing in Sri Lanka (formerly known as J.L. Morison’s Son & Jones (Ceylon) PLC), commenced manufacturing of Bisoprolol tablets B.P. 5mg 250s, Ros-10 (Rosuvastatin tablets I.P. 10mg 30s blister), and ChlorMor (Chlorphenamine tablets B.P. 4mg 100s blister) recently. This marks a milestone in the local pharmaceutical industry, as these high-in-demand medicines are now more affordable and accessible to our people, the supply of which does not have to depend on imports.

For the first time in Sri Lanka, Bisoprolol 5 mg tablets are now being manufactured locally by Morison and supplied to the Medical Supplies Division for the use in government hospitals. Used as a treatment for high blood pressure and other cardiovascular conditions, the annual requirement of Bisoprolol in the government sector is around 40 million tablets, which was being imported to date. By producing the same locally, Morison is able to make a significant forex saving for the national economy during these unprecedented times. Plans are underway to make Bisoprolol B.P. 2.5mg and 5 mg available in all leading pharmacies as a branded medication in due course, to enable purchasing through a valid prescription.

The second new product launched, Ros-10 (Rosuvastatin tablets I.P. 10mg 30s blister) is used to treat high blood cholesterol, a risk factor for cardiovascular disease. Morison launched Ros-10 at approximately half of the current weighted average market price, offering significant savings to Sri Lankans. The third latest addition to the Morison portfolio, ChlorMor (Chlorphenamine tablets B.P. 4mg 100s blister) is an oral antihistamine that helps to relieve symptoms of allergies. This too was launched at a price less than the prevailing similar products in the market.

Dinesh Athapaththu, Managing Director of Morison Limited, commented on the commencement of production of these pharmaceuticals saying, “This indeed is a key milestone for Morison as well as the pharmaceutical manufacturing industry in the country. Our purpose is to “Make Premium Healthcare Affordable”, and this is what we aim at achieving as we supply to the local demand for a lesser price, while maintaining the highest standards of quality. We commenced operations of our latest state-of-the-art manufacturing and research facility in Homagama in May this year, which is the largest investment to date in the pharmaceutical manufacturing industry in Sri Lanka. This will be a great boost for the pharmaceutical supply of the country during this crucial hour. As a subsidiary of the Hemas Group, Morison continues to receive the best of technology and knowledge investment in our journey.”

Being the first and largest general oral solid dosage (OSD) and oral liquid dosage (OLD) manufacturing facility in compliance with WHO GMP and EU GMP infrastructure and quality management systems in Sri Lanka, the Morison’s second manufacturing facility in Homagama, has the inbuilt capacity to produce 5 Bn tablets and 2 Mn litres of liquids per annum, which is equivalent to 40% of the national annual general OSD demand in Sri Lanka.

Prior to introducing Ros-10, Bisoprolol and ChlorMor, Morison launched the first ever locally manufactured SGLT2 molecule (Sodium-glucose cotransporter-2), Empagliflozin tablets 10mg and 25mg in 2021. An oral medication to treat Type 2 Diabetes, this was launched at approximately 50% price advantage from the market. The launch of the three new products is yet another progressive step of Morison, towards being a beacon of hope to Sri Lankans by “Making Premium Healthcare Affordable” in this critical juncture.



Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

“RDB Drives Unprecedented Growth with Record Profits Fueling Expansion and Development Impact” 

Published

on

The Regional Development Bank (RDB) delivered an exceptional financial performance for the year ended 31 December 2025, recording an 86% year-on-year increase in Profit After Tax to LKR 2.37 billion. The Bank’s total income reached LKR 42.81 billion, driven by a 23.89% growth in Net Interest Income to LKR 24.23 billion, complemented by steady contributions from both interest and fee-based income streams. This performance highlights the Bank’s ability to optimise its asset base while sustaining a well-diversified and resilient revenue profile.

Marking its 40th anniversary in 2025, the Bank’s exemplary performance underscores the strength of its resilient operating model, disciplined execution, and its growing role as a catalyst for inclusive economic progress in Sri Lanka. Profitability metrics strengthened notably, with Return on Assets (ROA) improving to 1.70% and Return on Equity (ROE) increasing to 11.77%, demonstrating enhanced efficiency in capital deployment and earnings generation.

Commenting on the Bank’s performance, Chairman Lasantha Fernando stated,

“Our performance in 2025 reflects the strength of a purpose-driven banking model that successfully balances financial sustainability with national development priorities. As Sri Lanka progresses on its path to recovery, our commitment to enabling inclusive growth remains unwavering.”

The Bank continued to expand its development-focused lending portfolio, with loans and receivables growing by 23.59% to LKR 302.54 billion. This growth supported priority sectors including agriculture, SMEs, manufacturing, housing, and rural enterprises representing segments critical to national economic revitalisation. Importantly, this expansion was achieved alongside improved asset quality, with the Stage 3 impaired loans ratio declining to 4.06% from 6.25%, demonstrating robust credit risk management and effective recovery strategies.

Customer confidence remained strong, with deposits increasing by 11.85% to LKR 283.72 billion, driven by growth in both savings and fixed deposits. The Bank also maintained liquidity ratios well above regulatory thresholds, reinforcing its financial stability and resilience

Asanga Tennakoon General Manager/Chief Executive Officer, highlighted” last year’s results underscore the impact of disciplined execution, prudent risk management, and a strong customer-centric approach. Looking ahead, we will continue to expand our reach, strengthen digital capabilities, and deepen financial inclusion to create sustainable value for all stakeholders.”

Continue Reading

Business

SLIC Life and SLIC General Create New Employment Opportunities

Published

on

New Trainee Insurance Assistants receiving their appointment letters from (L-R) Nalin Subasinghe (CEO of SLICLL), Nusith Kumaratunga (Chairman of SLIC) and Dr. Sameera Dharmasena (CEO of SLICGL

Sri Lanka Insurance Life Ltd (SLICLL) and Sri Lanka Insurance General Ltd (SLICGL) together appointed 112 Trainee Insurance Assistants, marking one of the largest recruitments across both companies in recent years.

Of the total intake, 87 candidates joined SLICGL while 25 candidates were appointed to SLICLL. This recruitment reflects the continued efforts of both companies to strengthen their workforce while contributing to employment opportunities.

The recruitment process was conducted through a structured and independent evaluation framework to ensure transparency and merit-based selection. Applications were invited from eligible candidates island-wide, followed by a written examination. Candidates who met the required benchmarks were shortlisted for interviews conducted by an independent panel, reinforcing fairness and credibility throughout the process.

The newly appointed Trainee Insurance Assistants represent a diverse and capable talent pool. Approximately 30% of the recruits are graduates, while all candidates possess the required academic qualifications, including G.C.E. Ordinary Level and Advanced Level certifications, or equivalent diplomas and higher qualifications.

This intake is aligned with the long-term focus of SLICLL and SLICGL on developing human capital and nurturing future-ready professionals within the insurance industry. The new recruits will have access to structured career growth opportunities, enabling them to build sustainable careers within the organisations. Efforts have also been made to assign employees to locations closest to their places of residence, subject to operational requirements, ensuring both efficiency and employee convenience.

Commenting on the appointments, Nusith Kumaratunga, Chairman of Sri Lanka Insurance stated, “The onboarding of this new group of Trainee Insurance Assistants reflected our continued focus on building strong and capable teams across both SLICLL and SLICGL. By maintaining a transparent and merit-based selection process, we remained committed to creating opportunities for talented individuals while strengthening the foundations for long-term organisational growth. This initiative also aligned with our broader role in supporting employment generation and contributing to the country’s economic progress.”

The official appointment ceremony was held on 7th April 2026 at the SLIC Head Office, in the presence of the Chairman and the Corporate Management of SLICLL and SLICGL, marking an important milestone in the organisations’ ongoing people development journey.

Continue Reading

Business

99x Wins Five Awards at Best Management Practices Awards ‘26, Showcasing AI-led Transformation

Published

on

Team 99x winning the Overall Gold Award at the CPM Best Management Practices Awards 2026

99x, a leading global product engineering company, has secured five major accolades at the CPM Best Management Practices Awards 2026, including an Overall Gold Award, positioning the company among Sri Lanka’s top-performing organisations in management excellence. The company was also recognised as the Sector Winner for IT, Software & BPO Services, named among the Forty Outstanding Companies, and received the Best Management Practices Excellence Award. In addition, Hasith Yaggahavita, CEO of 99x, was honoured with the Leadership Excellence Award, acknowledging his role in driving the organisation’s AI-led transformation.

The recognition was awarded for 99x’s submission titled ‘Embracing AI: Rethinking Talent, Products & Services,’ which addressed one of the most pressing shifts facing the global technology services industry today. As AI continues to redefine how software is built and delivered, traditional outsourcing models are being challenged from reduced reliance on large engineering teams to a growing shift toward outcome-based delivery and faster go-to-market expectations.

Chatura De Silva, Chief AI Officer at 99x, stated, “Winning five awards at one stage is a proud moment for us as a team. While AI is driving change across the industry, what made this possible is how we chose to adapt to it. We recognised that AI is not just a layer on top of what we do, but that it changes the foundation of how value is created. This transformation was about connecting both our talent and delivery, while embedding AI across everything we do”.

Selected from over 150 award submissions, 99x was also among the top 10 organisations invited to present its journey at the CPM Management Insights Summit 2026, placing its transformation on a national stage among the country’s most forward-thinking enterprises. Chatura De Silva, Kalana Wijesekara, Chief Developer Experience Officer and Chrishan de Mel, Chief Marketing and Corporate Affairs Officer, presented 99x’s story.

Commenting on the significance of this year’s awards, Dilshan Arsakularathna, CEO of The Institute of Chartered Professional Managers of Sri Lanka, stated, “99x securing the Overall Gold Award among organisations across multiple industries reflects the level at which Sri Lanka’s IT sector is progressing today. It demonstrates how companies are building real capability and driving innovation that can confidently stand on a global stage. Notably, 99x has now become the first organisation to secure the Overall Gold Award twice across the five editions of the BMPC Awards. This remarkable achievement reflects their strong commitment to sustaining excellence and continuously embedding best management practices within their operations. What stood out with 99x was how they have adapted to change in a practical and forward-thinking manner, reshaping how they operate and deliver value, while setting a compelling benchmark for modern management practices.”

Continue Reading

Trending